Catalyst Wire Dossier Catalyst Wire Dossier

BFKB8488A

· Genentech, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BFKB8488A, covering 2018-05-01 to 2024-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis [Phase 2]

See pricing